Dr Tricia Tan is a Consultant in Diabetes, Endocrinology and Metabolic Medicine at Imperial College London and NHS Trust. She possesses over 10 years’ experience in gut hormone research and physiological studies into the impact of gut hormones on weight and T2DM. She has completed several Phase I trials on the gut hormone analogues, which are being developed for the treatment of obesity. She is the director of the SAS Gut Hormone service, and her clinical research spans a wide gamut from the diagnosis and treatment of neuroendocrine tumours to diagnostic testing in Endocrine disorders.
et al., 2008, MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress., Clin Endocrinol (oxf)
et al., 2017, Thermal imaging is a non-invasive alternative to PET-CT for measurement of brown adipose tissue activity in humans., J Nucl Med
et al., 2017, RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling, Endocrinology, Vol:158, ISSN:0013-7227, Pages:2680-2693
et al., 2017, The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers, Journal of Clinical Endocrinology & Metabolism, Vol:102, ISSN:0021-972X, Pages:2364-2372
et al., 2017, Degradation Paradigm of the Gut Hormone, Pancreatic Polypeptide, by Hepatic and Renal Peptidases, Endocrinology, Vol:158, ISSN:0013-7227, Pages:1755-1765